Tuesday, March 2, 2021

Cassava Stock

- Advertisement -

Cassava Sciences Stock Soared 130% on Monday Followed by Positive Results of New Alzheimer’s Phase 2 Trials

The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a phase 2 study. Cassava Sciences...
- Advertisement -

Must Read

Johnson & Johnson (JNJ) Is Granted FDA Approval For Their COVID-19 Vaccine

Johnson & Johnson (JNJ) has been granted permission by the Office of Food and Drug Administration (FDA) to use the emergency use vaccine COVID...
- Advertisement -

Earnings Preview for iQIYI Inc. (IQ): What to Expect From Earnings?

iQiyi (NASDAQ: IQ) released its most recent results for the fourth quarter and full year. Subscribers continue to leave the company, and which slows...

Genasys Inc (GNSS) Announces Contract With Spanish Interior Ministry

Genasys Inc (GNSS) announced it had secured a contract with the Spanish Ministry of the Interior for four years. The company will supply alert...

International Paper (IP) sells paper and pulp mill for $812M

In an agreement with Mayr-MelnhofKarton AG, International Paper has agreed to sell its Kwidzyn paper and pulp mill for an estimated $812 million in...